Walib Habib

Title: Innovations by Walib Habib in Fentanyl Administration

Introduction

Walib Habib is an accomplished inventor based in Crystal, MN (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the administration of fentanyl. With a total of 2 patents to his name, his work focuses on improving the efficacy and safety of fentanyl dosage forms.

Latest Patents

Walib's latest patents include innovative approaches to fentanyl administration. The first patent describes effervescent oral fentanyl dosage forms and methods of administering fentanyl. These dosage forms contain substantially less fentanyl by weight than known oral formulations, offering advantages in terms of reduced cost and side effects. They are specifically designed for oral administration of fentanyl across the oral mucosa. The second patent also focuses on generally linear effervescent oral fentanyl dosage forms and methods of administering them. Similar to the first, these dosage forms aim to enhance the delivery of fentanyl while minimizing adverse effects and costs.

Career Highlights

Walib Habib is currently employed at Cephalon, Inc., where he continues to develop innovative pharmaceutical solutions. His work has been instrumental in advancing the field of pain management through improved drug delivery systems.

Collaborations

Walib collaborates with notable colleagues, including Derek V Moe and Vikas Agarwal. Their combined expertise contributes to the successful development of new pharmaceutical formulations.

Conclusion

Walib Habib's contributions to fentanyl administration represent a significant advancement in pharmaceutical innovation. His patents reflect a commitment to improving patient outcomes through safer and more effective drug delivery methods.